2013, Número 1
<< Anterior Siguiente >>
Ann Hepatol 2013; 12 (1)
Use of acetylcysteine for non-acetaminophen-induced acute liver failure
Sales I, Dzierba AL, Smithburger PL, Rowe D, Kane-Gill SL
Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 6-10
Archivo PDF: 83.13 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
Lee WM, Squires RH Jr., Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008; 47: 1401-15. Doi:10.1002/hep.22177.
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-54. Available from: www.annals.org+947.long
Lee WM LA, Stravitz RT. AASLD Position Paper: The Management of Acute Liver Failure: Update 2011. Hepatology 2001. Epup 2011, Sept. 1. Available from: www.aasld.org/ p racticeguidelines/Documents/AcuteLiverFailureUpdate2011.pdf
Harrison P, Wendon J, Williams R. Evidence of increased guanylatecyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996; 23: 1067-72. Doi:10.1002/hep.510230520.
Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 1997; 25: 236-42. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/9034257?dopt=Citation
Flanagan RJ, Meredith TJ. The use of N-acetylcysteine in clinical toxicology. Am J Med 1991; 30; 91(3C): 131S-139S. Doi:10.1016/0002-9343(91)90296-A.
Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-7. Doi:10.1056/NEJM199106273242604.
Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother 2004; 38: 498-500. Doi: 10.1345/aph.1D209.
Janes SE, Price CS, Thomas D. Essential oil poisoning: Nacetylcysteine for eugenol-induced hepatic failure and analysis of a national database. Eur J Pediatr 2005; 164: 520-2. Doi:10.1007/s00431-005-1692-1.
Eisen JS, Koren G, Juurlink DN, Ng VL. N-acetylcysteine for the treatment of clove oil-induced fulminant hepatic failure. J Toxicol Clin Toxicol 2004; 42: 89-92. Doi:10.1081/CLT-120028751.
Daram SR, Hayashi PH. Acute liver failure due to iron overdose in an adult. South Med J 2005; 98: 241-4. Doi:10.1097/01.SMJ.0000152546.05519.FE.
Assy N, Gefen H, Schlesinger S, Hussein O. The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure. Dig Dis Sci 2007; 52: 3507-10. Doi:10.1007/s10620-006-9594-2.
Sotelo N, de los Angeles Durazo M, Gonzalez A, Dhanakotti N. Early treatment with N-acetylcysteine in children with acute liver failure secondary to hepatitis A. Ann Hepatol 2009; 8: 353-8. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/20009135
Tuccori M, Guidi B, Montagnani S, Fornai M, Antonioli L, Blandizzi C, di Paolo M. Transient acute liver failure complicating transurethral resection syndrome. Scand J Urol- Nephrol 2010; 44: 269-72. Doi:10.3109/ 00365591003636612.
Kumarasena RS, Mananjala Senanayake S, Sivaraman K, de Silva AP, Dassanayake AS, Premaratna R, Wijesiriwardena B, et al. Intravenous N-acetylcysteine in dengue-associated acute liver failure. Hepatol Int 2010; 4: 533-4. Doi:10.1007/s12072-010-9176-4.
Cheung MC, Jones RL, Judson I. Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report. J Med Case Reports 2011; 5: 180. Doi:10.1186/1752-1947- 5-180.
Thompson DC, Barhoumi R, Burghardt RC. Comparative toxicity of eugenol and its quinonemethide metabolite in cultured liver cells using kinetic fluorescence bioassays. ToxicolApplPharmacol 1998; 149(1): 55-63. Doi:10.1006/ taap.1997.8348.
Thompson DC, Constantin-Teodosiu D, Moldeus P. Metabolism and cytotoxicity of eugenol in isolated rat hepatocytes. ChemBiol Interact 1991; 77: 137-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1991333.
Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli- Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl 2008; 14: 25-30. Doi: 10.1002/ lt.21246.
Mumtaz K, Azam Z, Hamid S, Abid S, Memon S, Ali Shah H, Jafri W. Role of N-acetylcysteine in adults with non-acetaminophen- induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009; 3: 563-70. Doi:10.1007/s12072-009-9151-0.
Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern DJ 2nd., et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-64, 64 e1. Doi:10.1053/j.gastro.2009.06. 006.